NEW YORK, Nov. 6, 2017 /PRNewswire/ -- At least 30% of the haematologists we surveyed don't prescribe the 7 leading haemophiliaB treatments we asked them about. But most are willing to consider them, so there's room for brands to grow. To seize that opportunity, you need to understand the market barriers that are preventing doctors from prescribing your brand, and address the
Insight into 6 Major Haemophilia B DrugsAlprolix (eftrenonacog alfa; Bioverativ) BeneFIX (nonacog alfa; Pfizer) Feiba (Anti-Inhibitor Coagulant Complex; Shire) Idelvion (albutrepenonacog alfa; CSL Behring) MonoNine (Coagulation Factor IX [human]; CSL Behring) Rixubis (nonacog gamma; Shire) Exploring on Market Access issuesMarket Access Impact: Haemophilia B (US) explores key issues affecting drug manufacturers. You'll learn: How barriers affect market access: Which brands are physicians prescribing the most? How are prescribing decisions being affected by market barriers? Are some barriers having more impact than others? How barriers affect your brand:How many doctors prescribe your brand? How many don't, but would consider it? Why don't doctors prescribe your brand? What do they choose instead?vWhich competing brands does your brand take market share from? A Report Based on Expert KnowledgeWe surveyed 100 US-based haematologists, chosen from the largest community of validated physicians in the world. All respondents have:Been practising for 2+ years Prescribed at least one of the listed products Seen at least 5 patients with haemophilia B in total in the last month We conducted the survey between 1st and 12th May 2017.
Read the full report: https://www.reportlinker.com/p05175252 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/market-access-impact-haemophilia-b-us-300550382.html
Subscribe to our Free Newsletters!
Trichotillomania (TTM) is a hair pulling disorder where a person urges to pull out hair from their ...
Dental Anxiety is kind of dental phobia where a person has a fear of going to dentist mainly due to ...
Kleine Levin (KLS) or sleeping beauty syndrome is a rare neurological disorder that primarly ...View All